Edward N Cha, Age 47San Carlos, CA

Edward Cha Phones & Addresses

San Carlos, CA

Sunnyvale, CA

Palo Alto, CA

San Francisco, CA

100 Haven Ave #B, New York, NY 10032

Monmouth Junction, NJ

Plainsboro, NJ

Princeton, NJ

Lanham, MD

Garner, NC

Show more

Work

Address: 1425 S Main St, Walnut Creek, CA 94596 Specialities: Anesthesiologist

Mentions for Edward N Cha

Career records & work history

Medicine Doctors

Edward Cha Photo 1

Dr. Edward Y Cha, Walnut Creek CA - MD (Doctor of Medicine)

Specialties:
Anesthesiology
Age:
51
Address:
Kaiser Walnut Creek Medical Grp
1425 S Main St, Walnut Creek, CA 94596
(925) 295-4000 (Phone)
Certifications:
Anesthesiology, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Spanish
Vietnamese
Hospitals:
UC-SAN FRANCISCO
505 Parnassus Ave Suite 1270, San Francisco, CA 94143
UCSF Medical Center
505 Parnassus Avenue, San Francisco, CA 94143
Kaiser Walnut Creek Medical Grp
1425 S Main St, Walnut Creek, CA 94596
Kaiser Permanente Walnut Creek Medical Center
1425 South Main Street, Walnut Creek, CA 94596
Education:
Medical School
Tufts University School Of Medicine
Graduated: 2004
Edward Cha Photo 2

Dr. Edward N Cha, San Francisco CA - MD (Doctor of Medicine)

Specialties:
Hematology
Hematology & Oncology
Address:
UC-SAN FRANCISCO
505 Parnassus Ave Suite 1270, San Francisco, CA 94143
(415) 719-4725 (Phone) (415) 476-6129 (Fax)
Languages:
English
Hospitals:
UC-SAN FRANCISCO
505 Parnassus Ave Suite 1270, San Francisco, CA 94143
UCSF Medical Center
505 Parnassus Avenue, San Francisco, CA 94143
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 2001

Edward Y. Cha

Specialties:
Anesthesiology
Work:
Kaiser Permanente Medical GroupKaiser Walnut Creek Medical Group
1425 S Main St, Walnut Creek, CA 94596
(925) 295-4000 (phone)
Site
Education:
Medical School
Tufts University School of Medicine
Graduated: 2004
Languages:
English, Spanish, Vietnamese
Description:
Dr. Cha graduated from the Tufts University School of Medicine in 2004. He works in Walnut Creek, CA and specializes in Anesthesiology. Dr. Cha is affiliated with Kaiser Permanente Walnut Creek Medical Center.
Edward Cha Photo 3

Edward Yoonmyung Cha, Walnut Creek CA

Specialties:
Anesthesiologist
Address:
1425 S Main St, Walnut Creek, CA 94596

Edward Cha resumes & CV records

Resumes

Edward Cha Photo 30

Client Services & Insurance Practice Leader At Wells Fargo Insurance

Location:
Chicago, Illinois
Industry:
Insurance
Skills:
Employee Benefits, Mergers, Valuation, Data Analysis, Insurance, Pensions, Analysis, Human Resources, International, Global Health, Global Strategy, Leadership, Management, Start-ups, Performance Management, CRM, Mergers & Acquisitions, Strategic Planning, Nonprofits, EMEA, BRIC, APAC, Americas, Benefits Design, Benefits Management, Program Management, Team Leadership, Global Mobility, Global Management
Edward Cha Photo 31

Assistant Medical Director At Genentech

Position:
Assistant Medical Director at Genentech
Location:
San Francisco, California
Industry:
Research
Work:
Genentech - South San Francisco since May 2013
Assistant Medical Director
UCSF Medical Center - Division of Hematology and Oncology Jul 2010 - May 2013
Clinical Instructor of Melanoma and Cutaneous Oncology
UCSF - Division of Hematology and Oncology Jul 2009 - May 2013
Postdoctoral Fellow
UCSF - Division of Hematology and Oncology Jul 2008 - Jun 2010
Clinical Fellow in Medical Oncology
Mount Sinai Medical Center Jul 2005 - Jun 2008
Residency, Internal Medicine
Education:
Columbia University College of Physicians and Surgeons 1997 - 2005
M.D., Ph.D., Integrated Program in Cellular, Molecular and Biophysical Studies
Princeton University 1994 - 1997
A.B., Molecular Biology
Honor & Awards:
Conquer Cancer Foundation of ASCO, Young Investigator Award, 2011-2012

Publications & IP owners

Us Patents

Drip And Splatter Proof Paint Applicator

US Patent:
4767229, Aug 30, 1988
Filed:
Oct 16, 1987
Appl. No.:
7/109414
Inventors:
Edward Cha - Port Washington NY
International Classification:
B05C 1700
B05C 1702
US Classification:
401208
Abstract:
A drip and splatter proof paint applicator is provided. The paint is placed and contained within a housing so as to be dispensed therefrom by an endless belt paint roller unit. The paint roller unit can be quickly disengaged therefrom so that the residue paint within the housing and on the paint roller unit can be cleaned after each use.

Treatment With Anti-Tigit Antibodies And Pd-1 Axis Binding Antagonists

US Patent:
2021039, Dec 23, 2021
Filed:
Jan 26, 2021
Appl. No.:
17/159063
Inventors:
- South San Francisco CA, US
- Little Falls NJ, US
Yifan WANG - Shanghai, CN
Edward Namserk CHA - San Carlos CA, US
Feijiao GE - Shanghai, CN
International Classification:
C07K 16/28
A61P 35/00
A61K 33/243
A61N 5/00
A61K 31/337
Abstract:
The present invention relates to the treatment of esophageal cancer, e.g., esophageal squamous cell carcinoma (ESCC) (e.g., advanced ESCC (e.g., unresectable, locally advanced, recurrent, and/or metastatic ESCC)). More specifically, the invention pertains to the treatment of patients having esophageal cancer by administering a combination of an anti-T-cell immunoreceptor with Ig and ITIM domains (TIGIT) antagonist antibody and a programmed death-1 (PD-1) axis binding antagonist.

Combination Therapy For Cancer Comprising Pd-1 Axis Binding Antagonist And Il6 Antagonist

US Patent:
2021033, Oct 28, 2021
Filed:
Mar 4, 2021
Appl. No.:
17/249530
Inventors:
- South San Francisco CA, US
Joanna E. Klementowicz - South San Francisco CA, US
Yijin Li - South San Francisco CA, US
Li-Fen Liu - South San Francisco CA, US
Sanjeev Mariathasan - South San Francisco CA, US
Mark Merchant - South San Francisco CA, US
Luciana Molinero - South San Francisco CA, US
Lifen Wang - South San Francisco CA, US
Nathaniel West - Pacifica CA, US
Patrick Williams - San Francisco CA, US
Chi Yung Yuen - South San Francisco CA, US
Edward Namserk Cha - South San Francisco CA, US
Yulei Wang - South San Francisco CA, US
Assignee:
Genentech, Inc. - South San Francisco CA
International Classification:
C07K 16/28
A61P 35/00
A61K 31/337
A61K 47/64
Abstract:
This application discloses methods and compositions for use in treating cancer, including breast cancer (such as metastatic triple negative breast cancer, mTNBC), urothelial carcinoma, renal cell carcinoma, and liver cancer (hepatocellular carcinoma, HCC) with the combination of a PD-1 axis binding antagonist (e.g., a PD-L1 binding antibody such as atezolizumab) and an IL6 antagonist (e.g. an anti-IL6 receptor antibody such as tocilizumab), optionally further comprising a VEGF antagonist (e.g. an anti-VEGF antibody such as bevacizumab). Optionally, the patient has C-reactive protein (CRP) and/or IL-6 level(s) above the upper limit of normal. Optionally, the cancer is PD-L1 positive.

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.